C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/139, 195/46,
C12N 5/02 (2006.01) C07K 16/00 (2006.01) C12N 15/00 (2006.01)
Patent
CA 1187010
17 CELL-DRIVEN VIRAL TRANSFER IN EUKARYOTES ABSTRACT OF THE DISCLOSURE Novel method, cells and compositions are provided involving transforming B-lymphocytes to provide immortali- zation for continuous production of monoclonal antibodies to a predetermined ligand. T-cell free B-lymphocytes are combined with an Epstein-Barr virus transformed cell sen- sitive to a cytotoxic agent which does not significantly affect the B-lymphocytes under conditions where the sen- sitive EBV transformed cell acting as the transfer agent is killed and efficiently transforms the B-lymphocyte recipient cells with EBV. The EBV transformed B-lymphocyte cells are amplified and cloned, the desired clones isolated in accordance with conventional techniques and then used for production of monoclonal antibodies.
416400
Fetherstonhaugh & Co.
Genetic Systems Corporation
LandOfFree
Cell-driven viral transfer in eukaryotes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell-driven viral transfer in eukaryotes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-driven viral transfer in eukaryotes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1170466